SYDNEY ROBOTICS SUMMIT 2017 SPONSORS
We would like to thank the following sponsors:
Device Technologies is Australasia’s largest independent provider of total healthcare solutions. Partnering with some of the world’s most innovative medical companies, we offer a comprehensive range - from high quality consumables, to advanced equipment, robotics and digital O.R.s. Supported by a dedicated team of over 650 highly skilled staff.
Teleflex is a leading global provider of medical devices for surgery, critical care and anaesthesia. We are focused on consolidating our presence in ANZ to integrate and expand our portfolio of products providing extended choice for Australian clinicians from a single source.
Through professionalism and integrity, it is our passion to be the supplier of choice in each therapy area we support, and to be recognised for our unparalleled standard of education and customer service.
Astellas Pharma Australia Pty Ltd is part of Astellas Pharma Inc, which is one of the world’s top 20 pharmaceutical companies, employing more than 17,000 people globally. A young and forward-thinking company, Astellas is dedicated to improving the lives of people around the world through providing exceptional medicines that change tomorrow for patients in need.
Headquartered in Tokyo, Astellas was founded in 2005 through the merger of Yamanouchi and Fujisawa, bringing together nearly two centuries of collective experience in producing pharmaceutical drugs.
About AstraZeneca Australia (80 words) AstraZeneca is the third largest pharmaceutical company operating in Australia, is one of the country’s largest manufacturers of medicines and is a key exporter to 30 international markets. AstraZeneca produces medicines in a range of therapeutic areas including cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca contributes significantly to clinical trials in Australia with approximately 50 concurrent trials. AstraZeneca’s innovative medicines are used by millions of patients worldwide.
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. AbbVie employs more than 28,000 people worldwide and markets medicines in over 170 countries. Our heritage in Australia reaches back more than 75 years and we employ more than 280 people here with a focus on Immunology, Liver Disease, Neuroscience and Oncology. Our therapies currently benefit more than 31,000 Australians.
Coloplast Urology manufactures and distributes a full range of urology products to help people who suffer from urological disorders such as erectile dysfunction (E.D.), urinary incontinence, weak pelvic muscles, kidney stones and enlarged prostate. Coloplast have three focus areas: Urology Single Use Devices, Female Pelvic Health and Men’s Health. All three areas are dedicated to developing devices that can make life easier for people suffering from intimate urological disorders. Coloplast is in continuous dialogue with surgeons and nurses to improve less invasive surgical therapies improving peoples’ lives. We are always working to constantly improve our products and streamline surgical procedures.
Douglass Hanly Moir Pathology (DHM) is a highly respected and well-established pathology practice serving doctors and their patients in the metropolitan area of Sydney and in many regional areas of New South Wales. We are medically managed by specialist pathologists and a highly qualified team of scientists and other professionals. Underlying everything we do is our aim to deliver a highly professional and personalised service to our referring doctors in order to provide the best possible pathology care for their patients. Our specially trained pathologists and scientists are supported by a network of highly trained, accredited collectors, couriers and administrative staff, who ensure speed and accuracy in the process. We have collection centres conveniently placed throughout the metropolitan and regional areas. DHM is fully accredited by NATA in conjunction with the Royal College of Pathologists of Australasia.
From creating the first sutures, to revolutionizing surgery with minimally-invasive procedures, Ethicon has made significant contributions in medical device technology to transform the way surgery has been done for more than 60 years.
Ipsen provides specialty medicines to Healthcare Professionals and their patients suffering from debilitating diseases.
At Ipsen, our passion is improving the lives of patients. We do this by working together to build partnerships based on trust and mutual respect with Healthcare Professionals.
Ipsen is the Australian affiliate of a global R & D focused pharmaceutical company.
Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care. From prevention to treatment, Sanofi transforms scientific innovation into healthcare solutions, in human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions, and consumer healthcare. Sanofi's 110,000 people, some 820 of them in Australia and New Zealand, are dedicated to making a difference to patients’ daily lives